| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.998 | 0 | 0.998 | Cathepsin B inhibitor | 0.124 0.01 DBMET00570 | ||
| 0.998 | 0.001 | 0.998 | Angiogenesis inhibitor | |||
| 0.997 | 0.002 | 0.997 | Analgesic | |||
| 0.997 | 0.002 | 0.997 | Antiinflammatory | |||
| 0.671 | 0.011 | 0.671 | Aldehyde oxidase inhibitor | 0.652 0.013 DBMET00551 0.587 0.021 DBMET00570 | ||
| 0.63 | 0.012 | 0.63 | 5 Hydroxytryptamine release stimulant | 0.606 0.014 DBMET00551 0.591 0.015 DBMET00570 | ||
| 0.576 | 0.004 | 0.708 | Cyclooxygenase inhibitor | 0.588 0.004 DBMET00551 0.708 0.003 DBMET00570 | DBMET00570 | |
| 0.554 | 0.01 | 0.554 | Cardiotonic | |||
| 0.487 | 0.004 | 0.487 | Hedgehog signaling inhibitor | |||
| 0.506 | 0.024 | 0.563 | GABA C receptor rho-3 antagonist | 0.563 0.012 DBMET00551 0.506 0.024 DBMET00570 | DBMET00551 | |
| 0.464 | 0.004 | 0.687 | Cyclooxygenase 2 inhibitor | 0.533 0.004 DBMET00551 0.687 0.003 DBMET00570 | DBMET00570 | |
| 0.453 | 0.007 | 0.549 | Alpha-N-acetylglucosaminidase inhibitor | 0.549 0.004 DBMET00551 0.453 0.007 DBMET00570 | DBMET00551 | |
| 0.446 | 0.004 | 0.446 | MAP kinase 12 inhibitor | 0.188 0.027 DBMET00551 0.164 0.035 DBMET00570 | ||
| 0.443 | 0.004 | 0.443 | MAP kinase 13 inhibitor | 0.158 0.032 DBMET00551 | ||
| 0.437 | 0.009 | 0.505 | 5 Hydroxytryptamine uptake stimulant | 0.505 0.004 DBMET00551 0.437 0.009 DBMET00570 | DBMET00551 | |
| 0.412 | 0.003 | 0.412 | H+/K+-transporting ATPase inhibitor | |||
| 0.413 | 0.005 | 0.413 | Aldehyde dehydrogenase inhibitor | 0.328 0.009 DBMET00551 0.32 0.01 DBMET00570 | ||
| 0.413 | 0.007 | 0.413 | Interleukin 6 antagonist | 0.202 0.039 DBMET00551 | ||
| 0.445 | 0.052 | 0.515 | Histamine release inhibitor | 0.515 0.024 DBMET00551 0.379 0.086 DBMET00570 | DBMET00551 | |
| 0.392 | 0.009 | 0.436 | Tyrosine 3 hydroxylase inhibitor | 0.424 0.006 DBMET00551 0.436 0.005 DBMET00570 | DBMET00570 | |
| 0.402 | 0.024 | 0.405 | Calcium channel activator | 0.405 0.023 DBMET00551 0.366 0.04 DBMET00570 | DBMET00551 | |
| 0.441 | 0.068 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.489 0.039 DBMET00551 0.441 0.068 DBMET00570 | DBMET00551 | |
| 0.348 | 0.007 | 0.436 | GABA C receptor agonist | 0.436 0.004 DBMET00551 0.348 0.007 DBMET00570 | DBMET00551 | |
| 0.344 | 0.008 | 0.344 | Histone acetyltransferase inhibitor | 0.204 0.063 DBMET00551 0.225 0.04 DBMET00570 | ||
| 0.36 | 0.027 | 0.414 | Peroxidase inhibitor | 0.414 0.019 DBMET00551 0.36 0.027 DBMET00570 | DBMET00551 | |
| 0.322 | 0.005 | 0.365 | Porphobilinogen synthase inhibitor | 0.365 0.004 DBMET00551 0.322 0.005 DBMET00570 | DBMET00551 | |
| 0.318 | 0.004 | 0.342 | Triose-phosphate isomerase inhibitor | 0.342 0.004 DBMET00551 0.318 0.004 DBMET00570 | DBMET00551 | |
| 0.303 | 0.004 | 0.303 | CYP2A6 inhibitor | 0.204 0.007 DBMET00551 0.103 0.034 DBMET00570 | ||
| 0.379 | 0.086 | 0.379 | Antibacterial | 0.249 0.178 DBMET00551 0.236 0.191 DBMET00570 | ||
| 0.311 | 0.021 | 0.311 | Peptidyltransferase inhibitor | 0.221 0.075 DBMET00551 0.225 0.071 DBMET00570 | ||
| 0.293 | 0.005 | 0.313 | 5 Hydroxytryptamine 3E antagonist | 0.313 0.004 DBMET00551 0.293 0.005 DBMET00570 | DBMET00551 | |
| 0.316 | 0.047 | 0.316 | Antiamyloidogenic | |||
| 0.276 | 0.01 | 0.336 | Ferrochelatase inhibitor | 0.336 0.005 DBMET00551 0.276 0.01 DBMET00570 | DBMET00551 | |
| 0.283 | 0.025 | 0.283 | Diuretic | 0.173 0.058 DBMET00551 0.179 0.054 DBMET00570 | ||
| 0.38 | 0.123 | 0.494 | Caspase 9 stimulant | 0.494 0.062 DBMET00551 0.405 0.108 DBMET00570 | DBMET00551 | |
| 0.297 | 0.055 | 0.31 | Transcription factor STAT3 inhibitor | 0.263 0.074 DBMET00551 0.31 0.048 DBMET00570 | DBMET00570 | |
| 0.351 | 0.114 | 0.45 | 5 Hydroxytryptamine release inhibitor | 0.45 0.051 DBMET00551 0.351 0.114 DBMET00570 | DBMET00551 | |
| 0.24 | 0.003 | 0.24 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.107 0.009 DBMET00551 0.087 0.014 DBMET00570 | ||
| 0.286 | 0.056 | 0.444 | Superoxide dismutase inhibitor | 0.444 0.02 DBMET00551 0.286 0.056 DBMET00570 | DBMET00551 | |
| 0.251 | 0.022 | 0.274 | Succinate dehydrogenase inhibitor | 0.274 0.016 DBMET00551 0.251 0.022 DBMET00570 | DBMET00551 | |
| 0.233 | 0.007 | 0.233 | Hematopoietic | |||
| 0.288 | 0.063 | 0.307 | Transcription factor STAT inhibitor | 0.262 0.078 DBMET00551 0.307 0.052 DBMET00570 | DBMET00570 | |
| 0.232 | 0.007 | 0.232 | MAP kinase 11 inhibitor | |||
| 0.285 | 0.06 | 0.564 | Tumour necrosis factor alpha release inhibitor | 0.564 0.009 DBMET00570 | DBMET00570 | |
| 0.275 | 0.053 | 0.278 | Gastrin inhibitor | 0.278 0.05 DBMET00551 0.255 0.074 DBMET00570 | DBMET00551 | |
| 0.297 | 0.079 | 0.297 | Immunostimulant | 0.254 0.095 DBMET00551 0.211 0.113 DBMET00570 | ||
| 0.283 | 0.064 | 0.283 | DNA damaging | 0.192 0.122 DBMET00551 0.174 0.141 DBMET00570 | ||
| 0.215 | 0.01 | 0.215 | Mucolytic | 0.166 0.024 DBMET00551 0.138 0.04 DBMET00570 | ||
| 0.249 | 0.05 | 0.368 | RNA-directed DNA polymerase inhibitor | 0.368 0.022 DBMET00551 0.262 0.043 DBMET00570 | DBMET00551 | |
| 0.214 | 0.018 | 0.214 | Expectorant | 0.148 0.036 DBMET00551 0.183 0.024 DBMET00570 | ||
| 0.201 | 0.007 | 0.28 | Phenylalanine 4-hydroxylase inhibitor | 0.28 0.004 DBMET00551 0.148 0.012 DBMET00570 | DBMET00551 | |
| 0.211 | 0.019 | 0.211 | Antibacterial (Helicobacter pylori) | 0.131 0.066 DBMET00551 0.141 0.055 DBMET00570 | ||
| 0.201 | 0.015 | 0.242 | Adenylate kinase inhibitor | 0.242 0.01 DBMET00551 0.201 0.015 DBMET00570 | DBMET00551 | |
| 0.197 | 0.013 | 0.197 | Alcohol dehydrogenase inhibitor | 0.113 0.04 DBMET00551 0.08 0.079 DBMET00570 | ||
| 0.198 | 0.018 | 0.261 | UDP-glucose 4-epimerase inhibitor | 0.261 0.012 DBMET00551 0.198 0.018 DBMET00570 | DBMET00551 | |
| 0.229 | 0.05 | 0.271 | Nitric-oxide synthase stimulant | 0.271 0.021 DBMET00551 0.229 0.05 DBMET00570 | DBMET00551 | |
| 0.251 | 0.074 | 0.278 | 5 Hydroxytryptamine 1E antagonist | 0.278 0.046 DBMET00551 0.251 0.074 DBMET00570 | DBMET00551 | |
| 0.204 | 0.029 | 0.233 | Arachidonic acid antagonist | 0.233 0.01 DBMET00551 0.204 0.029 DBMET00570 | DBMET00551 | |
| 0.19 | 0.015 | 0.213 | GABA C receptor antagonist | 0.213 0.01 DBMET00551 0.19 0.015 DBMET00570 | DBMET00551 | |
| 0.278 | 0.104 | 0.278 | Antithrombotic | 0.275 0.107 DBMET00551 0.221 0.152 DBMET00570 | ||
| 0.181 | 0.012 | 0.204 | NADH dehydrogenase inhibitor | 0.204 0.01 DBMET00551 0.181 0.012 DBMET00570 | DBMET00551 | |
| 0.185 | 0.016 | 0.185 | Pregnane X receptor agonist | 0.163 0.034 DBMET00551 0.168 0.028 DBMET00570 | ||
| 0.258 | 0.089 | 0.307 | Insulysin inhibitor | 0.307 0.054 DBMET00551 0.275 0.076 DBMET00570 | DBMET00551 | |
| 0.184 | 0.015 | 0.184 | Gastric antisecretory | 0.115 0.047 DBMET00551 0.115 0.047 DBMET00570 | ||
| 0.281 | 0.114 | 0.281 | Thioredoxin glutathione reductase inhibitor | |||
| 0.276 | 0.11 | 0.305 | Vasodilator, peripheral | 0.305 0.094 DBMET00551 0.215 0.159 DBMET00570 | DBMET00551 | |
| 0.199 | 0.033 | 0.199 | Interleukin 1 antagonist | |||
| 0.199 | 0.034 | 0.598 | Cyclooxygenase 1 inhibitor | 0.441 0.005 DBMET00551 0.598 0.004 DBMET00570 | DBMET00570 | |
| 0.195 | 0.032 | 0.23 | GABA C receptor rho-2 antagonist | 0.23 0.016 DBMET00551 0.195 0.032 DBMET00570 | DBMET00551 | |
| 0.183 | 0.021 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.166 0.039 DBMET00551 0.178 0.025 DBMET00570 | ||
| 0.164 | 0.003 | 0.164 | Exportin-1 inhibitor | 0.111 0.005 DBMET00551 0.104 0.008 DBMET00570 | ||
| 0.171 | 0.012 | 0.185 | Ca2+-transporting ATPase inhibitor | 0.185 0.005 DBMET00551 0.171 0.012 DBMET00570 | DBMET00551 | |
| 0.183 | 0.024 | 0.183 | Microtubule formation inhibitor | 0.165 0.03 DBMET00551 0.128 0.052 DBMET00570 | ||
| 0.17 | 0.012 | 0.17 | Analgesic, opioid | |||
| 0.19 | 0.036 | 0.19 | Monophenol monooxygenase inhibitor | |||
| 0.215 | 0.061 | 0.279 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.279 0.031 DBMET00551 0.229 0.053 DBMET00570 | DBMET00551 | |
| 0.172 | 0.018 | 0.173 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.033 DBMET00551 0.173 0.017 DBMET00570 | DBMET00570 | |
| 0.172 | 0.019 | 0.172 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.038 DBMET00551 0.167 0.023 DBMET00570 | ||
| 0.178 | 0.027 | 0.224 | Aminopeptidase B inhibitor | 0.224 0.017 DBMET00551 0.178 0.027 DBMET00570 | DBMET00551 | |
| 0.167 | 0.016 | 0.167 | Opioid delta receptor antagonist | |||
| 0.178 | 0.028 | 0.226 | Adenylate cyclase stimulant | 0.212 0.009 DBMET00551 0.226 0.006 DBMET00570 | DBMET00570 | |
| 0.182 | 0.034 | 0.214 | CF transmembrane conductance regulator agonist | 0.214 0.015 DBMET00551 0.182 0.034 DBMET00570 | DBMET00551 | |
| 0.151 | 0.004 | 0.151 | Phosphodiesterase VII inhibitor | |||
| 0.209 | 0.064 | 0.286 | Non-steroidal antiinflammatory agent | 0.235 0.05 DBMET00551 0.286 0.031 DBMET00570 | DBMET00570 | |
| 0.162 | 0.018 | 0.227 | Prolactin inhibitor | 0.227 0.005 DBMET00551 0.162 0.018 DBMET00570 | DBMET00551 | |
| 0.163 | 0.019 | 0.182 | Creatine kinase inhibitor | 0.182 0.014 DBMET00551 0.163 0.019 DBMET00570 | DBMET00551 | |
| 0.228 | 0.085 | 0.302 | DNA synthesis inhibitor | 0.302 0.043 DBMET00551 0.282 0.05 DBMET00570 | DBMET00551 | |
| 0.188 | 0.045 | 0.188 | Death-associated protein kinase 2 inhibitor | |||
| 0.153 | 0.011 | 0.171 | Carbamoyl phosphate synthetase inhibitor | 0.171 0.009 DBMET00551 0.153 0.011 DBMET00570 | DBMET00551 | |
| 0.158 | 0.017 | 0.181 | Phosphofructokinase-1 inhibitor | 0.181 0.013 DBMET00551 0.158 0.017 DBMET00570 | DBMET00551 | |
| 0.152 | 0.011 | 0.152 | Epoxide hydrolase inhibitor | 0.068 0.056 DBMET00551 | ||
| 0.143 | 0.004 | 0.143 | Nicotinic acid receptor 2 agonist | |||
| 0.26 | 0.125 | 0.29 | Vasodilator, coronary | 0.29 0.096 DBMET00551 0.243 0.142 DBMET00570 | DBMET00551 | |
| 0.19 | 0.056 | 0.198 | Antipruritic | 0.198 0.051 DBMET00551 0.172 0.072 DBMET00570 | DBMET00551 | |
| 0.157 | 0.024 | 0.224 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.224 0.012 DBMET00551 0.157 0.024 DBMET00570 | DBMET00551 | |
| 0.182 | 0.05 | 0.291 | Amylase inhibitor | 0.291 0.019 DBMET00551 0.182 0.05 DBMET00570 | DBMET00551 | |
| 0.149 | 0.022 | 0.185 | GABA C receptor rho-1 antagonist | 0.185 0.011 DBMET00551 0.149 0.022 DBMET00570 | DBMET00551 | |
| 0.138 | 0.011 | 0.21 | Alcohol oxidase inhibitor | 0.21 0.006 DBMET00551 0.138 0.011 DBMET00570 | DBMET00551 | |
| 0.2 | 0.074 | 0.399 | Anesthetic general | 0.399 0.017 DBMET00551 0.2 0.074 DBMET00570 | DBMET00551 | |
| 0.155 | 0.036 | 0.178 | Heat shock protein 70 antagonist | 0.178 0.013 DBMET00551 0.155 0.036 DBMET00570 | DBMET00551 | |
| 0.136 | 0.02 | 0.136 | Macrophage migration inhibitory factor inhibitor | 0.081 0.051 DBMET00551 | ||
| 0.158 | 0.042 | 0.167 | Alkylator | 0.159 0.042 DBMET00551 0.167 0.038 DBMET00570 | DBMET00570 | |
| 0.123 | 0.008 | 0.123 | Dopamine transporter inhibitor | |||
| 0.177 | 0.064 | 0.245 | Phospholipase C inhibitor | 0.245 0.026 DBMET00551 0.193 0.049 DBMET00570 | DBMET00551 | |
| 0.123 | 0.012 | 0.181 | Acyl-CoA dehydrogenase inhibitor | 0.181 0.007 DBMET00551 0.123 0.012 DBMET00570 | DBMET00551 | |
| 0.138 | 0.028 | 0.156 | Nitric-oxide synthase inhibitor | 0.156 0.02 DBMET00551 0.094 0.07 DBMET00570 | DBMET00551 | |
| 0.13 | 0.02 | 0.13 | Alpha adrenoreceptor agonist | 0.077 0.04 DBMET00551 0.059 0.056 DBMET00570 | ||
| 0.122 | 0.013 | 0.122 | Aminopeptidase microsomal inhibitor | |||
| 0.129 | 0.02 | 0.152 | Glutamate dehydrogenase inhibitor | 0.152 0.015 DBMET00551 0.129 0.02 DBMET00570 | DBMET00551 | |
| 0.122 | 0.013 | 0.16 | Biliverdin reductase inhibitor | 0.16 0.008 DBMET00551 0.122 0.013 DBMET00570 | DBMET00551 | |
| 0.137 | 0.03 | 0.162 | DOPA decarboxylase inhibitor | 0.162 0.016 DBMET00551 0.149 0.022 DBMET00570 | DBMET00551 | |
| 0.134 | 0.027 | 0.154 | Electrolyte absorption antagonist | 0.154 0.018 DBMET00551 0.134 0.027 DBMET00570 | DBMET00551 | |
| 0.133 | 0.03 | 0.135 | Acetylcholine release stimulant | 0.135 0.029 DBMET00551 0.122 0.045 DBMET00570 | DBMET00551 | |
| 0.188 | 0.087 | 0.188 | Psychostimulant | 0.17 0.1 DBMET00551 | ||
| 0.158 | 0.058 | 0.158 | Toll-Like receptor 9 antagonist | 0.108 0.101 DBMET00551 | ||
| 0.124 | 0.023 | 0.13 | Inducible nitric-oxide synthase inhibitor | 0.13 0.021 DBMET00551 0.08 0.063 DBMET00570 | DBMET00551 | |
| 0.112 | 0.012 | 0.112 | Protease 3C (Human rhinovirus) inhibitor | 0.101 0.015 DBMET00551 0.092 0.019 DBMET00570 | ||
| 0.249 | 0.15 | 0.342 | Calpain 2 inhibitor | 0.342 0.091 DBMET00551 0.195 0.192 DBMET00570 | DBMET00551 | |
| 0.139 | 0.041 | 0.169 | Interleukin 8 antagonist | 0.169 0.024 DBMET00551 0.121 0.06 DBMET00570 | DBMET00551 | |
| 0.117 | 0.022 | 0.147 | Glutamate decarboxylase inhibitor | 0.147 0.014 DBMET00551 0.117 0.022 DBMET00570 | DBMET00551 | |
| 0.122 | 0.028 | 0.141 | Glutamate (mGluR7) agonist | 0.141 0.016 DBMET00551 0.138 0.017 DBMET00570 | DBMET00551 | |
| 0.154 | 0.061 | 0.196 | Mannose-6-phosphate isomerase inhibitor | 0.196 0.033 DBMET00551 0.167 0.051 DBMET00570 | DBMET00551 | |
| 0.144 | 0.051 | 0.179 | Cathepsin H inhibitor | 0.179 0.03 DBMET00551 0.159 0.04 DBMET00570 | DBMET00551 | |
| 0.154 | 0.062 | 0.194 | Cell wall synthesis inhibitor | 0.194 0.032 DBMET00551 0.184 0.038 DBMET00570 | DBMET00551 | |
| 0.092 | 0.001 | 0.092 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 DBMET00551 0.013 0.003 DBMET00570 | ||
| 0.123 | 0.032 | 0.123 | MAP kinase kinase 1 inhibitor | 0.115 0.04 DBMET00551 0.12 0.035 DBMET00570 | ||
| 0.102 | 0.013 | 0.102 | Aminopeptidase N inhibitor | |||
| 0.096 | 0.006 | 0.096 | Neurokinin 3 antagonist | |||
| 0.104 | 0.015 | 0.12 | Purinergic P2X1 antagonist | 0.12 0.011 DBMET00551 0.104 0.015 DBMET00570 | DBMET00551 | |
| 0.113 | 0.025 | 0.113 | Histamine H2 receptor antagonist | 0.09 0.047 DBMET00551 0.08 0.066 DBMET00570 | ||
| 0.136 | 0.048 | 0.191 | Cystathionine beta-synthase inhibitor | 0.191 0.027 DBMET00551 0.136 0.048 DBMET00570 | DBMET00551 | |
| 0.119 | 0.032 | 0.181 | Lanosterol 14 alpha demethylase inhibitor | 0.167 0.007 DBMET00551 0.181 0.005 DBMET00570 | DBMET00570 | |
| 0.1 | 0.014 | 0.127 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.127 0.01 DBMET00551 0.1 0.014 DBMET00570 | DBMET00551 | |
| 0.181 | 0.096 | 0.26 | Neurotrophic factor enhancer | 0.26 0.033 DBMET00551 0.181 0.096 DBMET00570 | DBMET00551 | |
| 0.121 | 0.036 | 0.121 | Opioid antagonist | |||
| 0.089 | 0.006 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.1 0.005 DBMET00551 0.089 0.006 DBMET00570 | DBMET00551 | |
| 0.092 | 0.01 | 0.118 | Aconitate hydratase inhibitor | 0.118 0.006 DBMET00551 0.092 0.01 DBMET00570 | DBMET00551 | |
| 0.197 | 0.116 | 0.239 | Calpain inhibitor | 0.239 0.076 DBMET00551 0.195 0.118 DBMET00570 | DBMET00551 | |
| 0.105 | 0.024 | 0.136 | D-Ala-D-Ala ligase inhibitor | 0.136 0.008 DBMET00551 0.105 0.024 DBMET00570 | DBMET00551 | |
| 0.107 | 0.027 | 0.126 | Glycine receptor antagonist | 0.126 0.015 DBMET00551 0.107 0.027 DBMET00570 | DBMET00551 | |
| 0.162 | 0.082 | 0.166 | ATPase inhibitor | 0.166 0.077 DBMET00551 | DBMET00551 | |
| 0.119 | 0.04 | 0.136 | Anabolic | 0.136 0.027 DBMET00551 0.119 0.04 DBMET00570 | DBMET00551 | |
| 0.083 | 0.005 | 0.107 | Alpha 1d adrenoreceptor agonist | 0.107 0.003 DBMET00551 0.096 0.004 DBMET00570 | DBMET00551 | |
| 0.095 | 0.017 | 0.15 | Ornithine carbamoyltransferase inhibitor | 0.15 0.01 DBMET00551 0.095 0.017 DBMET00570 | DBMET00551 | |
| 0.088 | 0.01 | 0.103 | Calcium channel P-type blocker | 0.103 0.005 DBMET00551 0.083 0.012 DBMET00570 | DBMET00551 | |
| 0.109 | 0.031 | 0.109 | Adrenaline agonist | 0.084 0.053 DBMET00551 0.08 0.058 DBMET00570 | ||
| 0.103 | 0.026 | 0.12 | Aminopeptidase I inhibitor | 0.12 0.019 DBMET00551 0.103 0.026 DBMET00570 | DBMET00551 | |
| 0.105 | 0.028 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | 0.122 0.015 DBMET00551 0.105 0.028 DBMET00570 | DBMET00551 | |
| 0.085 | 0.008 | 0.086 | Dihydroorotate oxidase inhibitor | 0.086 0.008 DBMET00551 0.079 0.011 DBMET00570 | DBMET00551 | |
| 0.094 | 0.018 | 0.108 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.108 0.009 DBMET00551 0.094 0.018 DBMET00570 | DBMET00551 | |
| 0.13 | 0.055 | 0.13 | Protein kinase (CK2) alpha inhibitor | |||
| 0.081 | 0.008 | 0.104 | G protein-coupled receptor agonist | 0.042 0.023 DBMET00551 0.104 0.005 DBMET00570 | DBMET00570 | |
| 0.125 | 0.052 | 0.181 | 5 Hydroxytryptamine 3A agonist | 0.181 0.021 DBMET00551 0.125 0.052 DBMET00570 | DBMET00551 | |
| 0.092 | 0.021 | 0.127 | Argininosuccinate synthase inhibitor | 0.127 0.014 DBMET00551 0.092 0.021 DBMET00570 | DBMET00551 | |
| 0.084 | 0.014 | 0.084 | Transcription factor RelA inhibitor | 0.084 0.014 DBMET00551 0.082 0.015 DBMET00570 | ||
| 0.109 | 0.038 | 0.161 | Histamine N-methyltransferase inhibitor | 0.161 0.011 DBMET00551 0.109 0.038 DBMET00570 | DBMET00551 | |
| 0.149 | 0.079 | 0.178 | Interferon gamma antagonist | 0.178 0.052 DBMET00551 0.155 0.072 DBMET00570 | DBMET00551 | |
| 0.077 | 0.008 | 0.077 | Histamine H2 receptor agonist | 0.071 0.01 DBMET00551 0.072 0.01 DBMET00570 | ||
| 0.1 | 0.031 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.106 0.026 DBMET00551 0.091 0.04 DBMET00570 | DBMET00551 | |
| 0.156 | 0.087 | 0.182 | Neurotensin receptor agonist | 0.182 0.048 DBMET00551 0.159 0.081 DBMET00570 | DBMET00551 | |
| 0.092 | 0.024 | 0.105 | Vanilloid 4 agonist | 0.105 0.014 DBMET00551 0.092 0.024 DBMET00570 | DBMET00551 | |
| 0.088 | 0.02 | 0.088 | Aryl hydrocarbon receptor antagonist | 0.063 0.049 DBMET00551 | ||
| 0.193 | 0.126 | 0.193 | Spasmolytic | |||
| 0.157 | 0.09 | 0.223 | 3C-like protease (Human coronavirus) inhibitor | 0.223 0.04 DBMET00551 0.19 0.057 DBMET00570 | DBMET00551 | |
| 0.127 | 0.06 | 0.166 | Proteasome inhibitor | 0.138 0.054 DBMET00551 0.166 0.038 DBMET00570 | DBMET00570 | |
| 0.094 | 0.029 | 0.103 | CC chemokine 5 receptor agonist | 0.103 0.019 DBMET00551 0.102 0.019 DBMET00570 | DBMET00551 | |
| 0.121 | 0.056 | 0.169 | Photosensitizer | 0.169 0.022 DBMET00551 0.128 0.048 DBMET00570 | DBMET00551 | |
| 0.07 | 0.008 | 0.071 | Geranyltranstransferase inhibitor | 0.071 0.007 DBMET00551 0.062 0.012 DBMET00570 | DBMET00551 | |
| 0.083 | 0.021 | 0.107 | Glutamate (mGluR6) antagonist | 0.107 0.008 DBMET00551 0.083 0.021 DBMET00570 | DBMET00551 | |
| 0.114 | 0.052 | 0.138 | Carbonic anhydrase XV inhibitor | 0.138 0.036 DBMET00551 0.124 0.044 DBMET00570 | DBMET00551 | |
| 0.102 | 0.04 | 0.17 | Glutamate release inhibitor | 0.17 0.006 DBMET00551 0.109 0.031 DBMET00570 | DBMET00551 | |
| 0.075 | 0.014 | 0.085 | Alpha-mannosidase inhibitor | 0.085 0.009 DBMET00551 0.082 0.01 DBMET00570 | DBMET00551 | |
| 0.073 | 0.012 | 0.073 | Squalene epoxidase inhibitor | 0.066 0.016 DBMET00551 0.066 0.016 DBMET00570 | ||
| 0.067 | 0.006 | 0.086 | Glucose-dependent insulinotropic receptor agonist | 0.04 0.017 DBMET00551 0.086 0.005 DBMET00570 | DBMET00570 | |
| 0.067 | 0.007 | 0.067 | Purinergic P2X3 antagonist | |||
| 0.085 | 0.026 | 0.085 | Cannabinoid CB1 receptor agonist | 0.06 0.043 DBMET00551 0.057 0.046 DBMET00570 | ||
| 0.087 | 0.029 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.022 DBMET00551 0.081 0.043 DBMET00570 | DBMET00551 | |
| 0.112 | 0.054 | 0.112 | Protein kinase (CK2) inhibitor | |||
| 0.087 | 0.031 | 0.103 | Glycine receptor agonist | 0.103 0.019 DBMET00551 0.097 0.023 DBMET00570 | DBMET00551 | |
| 0.166 | 0.111 | 0.166 | Anticonvulsant | |||
| 0.064 | 0.01 | 0.064 | Nicotinic acid receptor agonist | 0.054 0.013 DBMET00551 0.033 0.03 DBMET00570 | ||
| 0.21 | 0.156 | 0.301 | Cholesterol antagonist | 0.301 0.091 DBMET00551 0.24 0.133 DBMET00570 | DBMET00551 | |
| 0.08 | 0.027 | 0.08 | Beta adrenoreceptor antagonist | 0.067 0.042 DBMET00551 0.073 0.034 DBMET00570 | ||
| 0.125 | 0.072 | 0.185 | Cyclooxygenase 3 inhibitor | 0.185 0.025 DBMET00551 0.125 0.072 DBMET00570 | DBMET00551 | |
| 0.06 | 0.007 | 0.063 | Glutamate (mGluR8) agonist | 0.063 0.006 DBMET00551 0.051 0.011 DBMET00570 | DBMET00551 | |
| 0.066 | 0.014 | 0.094 | Adenylate cyclase 1 inhibitor | 0.094 0.005 DBMET00551 0.066 0.014 DBMET00570 | DBMET00551 | |
| 0.091 | 0.039 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.021 DBMET00551 0.091 0.039 DBMET00570 | DBMET00551 | |
| 0.126 | 0.075 | 0.143 | Vanilloid 1 agonist | 0.143 0.046 DBMET00551 0.129 0.068 DBMET00570 | DBMET00551 | |
| 0.073 | 0.023 | 0.092 | Potassium channel intermediate-conductance Ca-activated blocker | 0.092 0.011 DBMET00551 0.088 0.013 DBMET00570 | DBMET00551 | |
| 0.06 | 0.01 | 0.06 | GABA uptake inhibitor | 0.045 0.02 DBMET00551 0.035 0.034 DBMET00570 | ||
| 0.088 | 0.039 | 0.129 | Keratolytic | 0.129 0.019 DBMET00551 0.103 0.029 DBMET00570 | DBMET00551 | |
| 0.078 | 0.03 | 0.094 | Glutamate (mGluR7) antagonist | 0.094 0.014 DBMET00551 0.078 0.03 DBMET00570 | DBMET00551 | |
| 0.063 | 0.016 | 0.099 | Alpha 1b adrenoreceptor agonist | 0.099 0.005 DBMET00551 0.086 0.006 DBMET00570 | DBMET00551 | |
| 0.083 | 0.036 | 0.083 | Calcium channel L-type blocker | 0.065 0.06 DBMET00551 | ||
| 0.062 | 0.016 | 0.072 | Mannosidase inhibitor | 0.072 0.011 DBMET00551 0.069 0.012 DBMET00570 | DBMET00551 | |
| 0.05 | 0.004 | 0.05 | DNA polymerase III inhibitor | |||
| 0.063 | 0.017 | 0.097 | Potassium channel (Inward rectifier) activator | 0.063 0.017 DBMET00551 0.097 0.005 DBMET00570 | DBMET00570 | |
| 0.056 | 0.011 | 0.056 | Prostacyclin antagonist | |||
| 0.053 | 0.008 | 0.053 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.044 0.011 DBMET00551 0.035 0.015 DBMET00570 | ||
| 0.076 | 0.032 | 0.126 | NMDA receptor glycine site agonist | 0.126 0.007 DBMET00551 0.076 0.032 DBMET00570 | DBMET00551 | |
| 0.055 | 0.01 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.062 0.006 DBMET00551 0.055 0.01 DBMET00570 | DBMET00551 | |
| 0.062 | 0.018 | 0.169 | Aldosterone antagonist | 0.08 0.011 DBMET00551 0.169 0.005 DBMET00570 | DBMET00570 | |
| 0.058 | 0.015 | 0.109 | Cytokine production stimulant | 0.09 0.004 DBMET00551 0.109 0.004 DBMET00570 | DBMET00570 | |
| 0.06 | 0.016 | 0.095 | Potassium channel (ATP-sensitive) activator | 0.06 0.016 DBMET00551 0.095 0.005 DBMET00570 | DBMET00570 | |
| 0.187 | 0.144 | 0.234 | Neuropeptide Y2 antagonist | 0.234 0.072 DBMET00551 0.182 0.155 DBMET00570 | DBMET00551 | |
| 0.098 | 0.056 | 0.119 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 DBMET00551 0.098 0.056 DBMET00570 | DBMET00551 | |
| 0.065 | 0.025 | 0.081 | Ryanodine receptor antagonist | 0.081 0.008 DBMET00551 0.07 0.017 DBMET00570 | DBMET00551 | |
| 0.045 | 0.004 | 0.047 | Alpha 2a adrenoreceptor agonist | 0.047 0.004 DBMET00551 0.046 0.004 DBMET00570 | DBMET00551 | |
| 0.097 | 0.057 | 0.097 | Bile acid receptor antagonist | 0.086 0.085 DBMET00551 | ||
| 0.117 | 0.077 | 0.157 | MAP kinase kinase inhibitor | 0.109 0.085 DBMET00551 0.157 0.047 DBMET00570 | DBMET00570 | |
| 0.052 | 0.013 | 0.068 | Fumarate hydratase inhibitor | 0.068 0.009 DBMET00551 0.052 0.013 DBMET00570 | DBMET00551 | |
| 0.054 | 0.015 | 0.078 | Dopamine D5 agonist | 0.078 0.006 DBMET00551 0.054 0.015 DBMET00570 | DBMET00551 | |
| 0.113 | 0.074 | 0.113 | Calcium channel N-type blocker | 0.101 0.094 DBMET00551 | ||
| 0.121 | 0.083 | 0.121 | Toll-Like receptor antagonist | 0.119 0.086 DBMET00570 | ||
| 0.063 | 0.025 | 0.07 | Pregnane X receptor antagonist | 0.069 0.015 DBMET00551 0.07 0.014 DBMET00570 | DBMET00570 | |
| 0.08 | 0.043 | 0.121 | Histidine decarboxylase inhibitor | 0.121 0.025 DBMET00551 0.08 0.043 DBMET00570 | DBMET00551 | |
| 0.075 | 0.039 | 0.103 | Acetylcholine M5 receptor agonist | 0.103 0.018 DBMET00551 0.086 0.03 DBMET00570 | DBMET00551 | |
| 0.05 | 0.014 | 0.058 | Kainate receptor agonist | 0.058 0.008 DBMET00551 0.05 0.014 DBMET00570 | DBMET00551 | |
| 0.071 | 0.035 | 0.127 | NMDA receptor agonist | 0.127 0.012 DBMET00551 0.071 0.035 DBMET00570 | DBMET00551 | |
| 0.051 | 0.016 | 0.051 | Angiotensin AT1 receptor antagonist | 0.045 0.024 DBMET00551 | ||
| 0.177 | 0.142 | 0.239 | Interleukin agonist | 0.239 0.087 DBMET00551 0.208 0.113 DBMET00570 | DBMET00551 | |
| 0.038 | 0.004 | 0.061 | Complement factor 1s inhibitor | 0.045 0.003 DBMET00551 0.061 0.002 DBMET00570 | DBMET00570 | |
| 0.066 | 0.033 | 0.066 | Dopamine uptake inhibitor | |||
| 0.05 | 0.017 | 0.064 | Dihydropteroate synthase inhibitor | 0.055 0.013 DBMET00551 0.064 0.01 DBMET00570 | DBMET00570 | |
| 0.055 | 0.023 | 0.055 | Collagenase inhibitor | |||
| 0.075 | 0.043 | 0.092 | Phospholipase D inhibitor | 0.092 0.021 DBMET00551 0.075 0.043 DBMET00570 | DBMET00551 | |
| 0.037 | 0.006 | 0.047 | Glutamate (mGluR1a) agonist | 0.047 0.005 DBMET00551 0.037 0.006 DBMET00570 | DBMET00551 | |
| 0.057 | 0.026 | 0.068 | Lysophosphatidic acid 3 receptor antagonist | 0.068 0.015 DBMET00551 0.057 0.026 DBMET00570 | DBMET00551 | |
| 0.038 | 0.008 | 0.038 | MAP3K8 inhibitor | 0.036 0.009 DBMET00551 0.036 0.01 DBMET00570 | ||
| 0.096 | 0.066 | 0.12 | Carbonic anhydrase III inhibitor | 0.12 0.044 DBMET00551 0.109 0.053 DBMET00570 | DBMET00551 | |
| 0.086 | 0.056 | 0.103 | mTOR complex 2 inhibitor | 0.103 0.03 DBMET00551 0.093 0.043 DBMET00570 | DBMET00551 | |
| 0.122 | 0.093 | 0.174 | Nav1.6 sodium channel blocker | 0.174 0.032 DBMET00551 0.122 0.093 DBMET00570 | DBMET00551 | |
| 0.069 | 0.04 | 0.112 | MDM2 inhibitor | 0.087 0.013 DBMET00551 0.112 0.005 DBMET00570 | DBMET00570 | |
| 0.062 | 0.033 | 0.083 | Carbonic anhydrase VB inhibitor | 0.083 0.021 DBMET00551 0.074 0.025 DBMET00570 | DBMET00551 | |
| 0.069 | 0.04 | 0.069 | Neutrophil collagenase inhibitor | 0.059 0.052 DBMET00551 0.057 0.054 DBMET00570 | ||
| 0.059 | 0.03 | 0.059 | Thromboxane synthase inhibitor | 0.051 0.047 DBMET00551 | ||
| 0.067 | 0.039 | 0.074 | Beta 3 adrenoreceptor antagonist | 0.074 0.029 DBMET00551 0.071 0.032 DBMET00570 | DBMET00551 | |
| 0.039 | 0.011 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 DBMET00551 0.037 0.013 DBMET00570 | DBMET00551 | |
| 0.153 | 0.126 | 0.182 | Focal adhesion kinase 2 inhibitor | 0.182 0.086 DBMET00551 0.168 0.103 DBMET00570 | DBMET00551 | |
| 0.064 | 0.037 | 0.085 | Corticotropin releasing factor 2 receptor antagonist | 0.085 0.013 DBMET00551 0.069 0.029 DBMET00570 | DBMET00551 | |
| 0.049 | 0.022 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.007 DBMET00551 0.049 0.022 DBMET00570 | DBMET00551 | |
| 0.031 | 0.005 | 0.031 | Ileal bile acid transport inhibitor | 0.022 0.008 DBMET00551 0.031 0.005 DBMET00570 | ||
| 0.061 | 0.035 | 0.062 | Alpha 1 adrenoreceptor agonist | 0.062 0.035 DBMET00551 0.062 0.034 DBMET00570 | DBMET00570 | |
| 0.035 | 0.01 | 0.041 | Purinergic P2Y15 antagonist | 0.041 0.006 DBMET00551 0.035 0.01 DBMET00570 | DBMET00551 | |
| 0.045 | 0.02 | 0.067 | Membrane dipeptidase inhibitor | 0.067 0.008 DBMET00551 0.061 0.01 DBMET00570 | DBMET00551 | |
| 0.074 | 0.049 | 0.074 | Metalloproteinase-9 inhibitor | 0.068 0.059 DBMET00551 0.07 0.055 DBMET00570 | ||
| 0.055 | 0.03 | 0.06 | Prolyl endopeptidase inhibitor | 0.06 0.024 DBMET00551 | DBMET00551 | |
| 0.05 | 0.025 | 0.061 | Fructose-1,6-bisphosphatase inhibitor | 0.061 0.017 DBMET00551 0.059 0.018 DBMET00570 | DBMET00551 | |
| 0.076 | 0.051 | 0.093 | GABA B receptor agonist | 0.093 0.023 DBMET00551 0.076 0.051 DBMET00570 | DBMET00551 | |
| 0.034 | 0.009 | 0.088 | Alpha 1a adrenoreceptor agonist | 0.038 0.008 DBMET00551 0.088 0.003 DBMET00570 | DBMET00570 | |
| 0.16 | 0.136 | 0.217 | Cyclic AMP phosphodiesterase inhibitor | 0.217 0.082 DBMET00551 | DBMET00551 | |
| 0.128 | 0.104 | 0.128 | Phospholipase A2 inhibitor | 0.128 0.103 DBMET00551 0.122 0.114 DBMET00570 | ||
| 0.075 | 0.051 | 0.124 | Catalase inhibitor | 0.124 0.032 DBMET00551 0.075 0.051 DBMET00570 | DBMET00551 | |
| 0.052 | 0.029 | 0.057 | HCV NS3/NS4A protease inhibitor | 0.057 0.024 DBMET00551 0.053 0.028 DBMET00570 | DBMET00551 | |
| 0.034 | 0.01 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET00551 0.034 0.01 DBMET00570 | DBMET00551 | |
| 0.055 | 0.032 | 0.055 | Thromboxane A2 antagonist | 0.051 0.035 DBMET00551 0.051 0.035 DBMET00570 | ||
| 0.027 | 0.005 | 0.035 | Carbonic anhydrase X inhibitor | 0.035 0.004 DBMET00551 0.027 0.005 DBMET00570 | DBMET00551 | |
| 0.027 | 0.005 | 0.035 | Carbonic anhydrase VIII inhibitor | 0.035 0.004 DBMET00551 0.027 0.005 DBMET00570 | DBMET00551 | |
| 0.046 | 0.024 | 0.059 | GABA B receptor antagonist | 0.059 0.013 DBMET00551 | DBMET00551 | |
| 0.052 | 0.03 | 0.077 | Topoisomerase II beta inhibitor | 0.077 0.014 DBMET00551 0.056 0.025 DBMET00570 | DBMET00551 | |
| 0.031 | 0.009 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DBMET00551 0.031 0.009 DBMET00570 | DBMET00551 | |
| 0.052 | 0.031 | 0.052 | Metalloproteinase-3 inhibitor | 0.043 0.042 DBMET00551 0.045 0.039 DBMET00570 | ||
| 0.027 | 0.005 | 0.027 | Toll-Like receptor 8 agonist | 0.019 0.017 DBMET00551 0.023 0.009 DBMET00570 | ||
| 0.031 | 0.01 | 0.04 | Hedgehog signaling activator | 0.04 0.005 DBMET00551 0.034 0.008 DBMET00570 | DBMET00551 | |
| 0.036 | 0.014 | 0.036 | Leukotriene B4 receptor 1 antagonist | |||
| 0.043 | 0.022 | 0.048 | AMPA 4 receptor antagonist | 0.048 0.017 DBMET00551 0.04 0.026 DBMET00570 | DBMET00551 | |
| 0.073 | 0.052 | 0.085 | Potassium channel (Tandem pore domain) blocker | 0.085 0.025 DBMET00551 0.076 0.045 DBMET00570 | DBMET00551 | |
| 0.039 | 0.019 | 0.039 | RNA-directed RNA polymerase inhibitor | 0.033 0.026 DBMET00551 0.034 0.024 DBMET00570 | ||
| 0.058 | 0.038 | 0.058 | Beta 1 adrenoreceptor antagonist | 0.05 0.046 DBMET00551 | ||
| 0.03 | 0.01 | 0.035 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.007 DBMET00551 0.03 0.01 DBMET00570 | DBMET00551 | |
| 0.055 | 0.035 | 0.055 | Leukotriene B4 antagonist | |||
| 0.024 | 0.004 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00551 0.02 0.009 DBMET00570 | ||
| 0.091 | 0.072 | 0.095 | Phosphodiesterase 6D inhibitor | 0.095 0.064 DBMET00551 | DBMET00551 | |
| 0.085 | 0.066 | 0.139 | Bromodomain-containing protein 2 inhibitor | 0.102 0.038 DBMET00551 0.139 0.013 DBMET00570 | DBMET00570 | |
| 0.036 | 0.017 | 0.036 | HCV NS5B polymerase inhibitor | 0.029 0.025 DBMET00551 0.034 0.019 DBMET00570 | ||
| 0.09 | 0.072 | 0.124 | Sphingomyelinase inhibitor | 0.124 0.038 DBMET00551 0.09 0.072 DBMET00570 | DBMET00551 | |
| 0.069 | 0.051 | 0.115 | Secretase beta inhibitor | 0.105 0.016 DBMET00551 0.115 0.012 DBMET00570 | DBMET00570 | |
| 0.045 | 0.027 | 0.053 | Histamine H1 receptor agonist | 0.053 0.014 DBMET00551 0.045 0.027 DBMET00570 | DBMET00551 | |
| 0.037 | 0.019 | 0.037 | Angiotensin II receptor antagonist | 0.033 0.027 DBMET00551 | ||
| 0.055 | 0.037 | 0.065 | Epithelial sodium channel blocker | 0.064 0.024 DBMET00551 0.065 0.022 DBMET00570 | DBMET00570 | |
| 0.062 | 0.043 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.032 DBMET00551 0.065 0.031 DBMET00570 | DBMET00570 | |
| 0.045 | 0.027 | 0.057 | Glutamate (mGluR4) antagonist | 0.057 0.015 DBMET00551 0.048 0.024 DBMET00570 | DBMET00551 | |
| 0.101 | 0.083 | 0.101 | Calcium channel (voltage-sensitive) blocker | |||
| 0.055 | 0.037 | 0.055 | Thromboxane antagonist | 0.051 0.041 DBMET00551 0.051 0.041 DBMET00570 | ||
| 0.04 | 0.022 | 0.045 | Delayed rectifier potassium channel blocker | 0.045 0.015 DBMET00551 0.04 0.022 DBMET00570 | DBMET00551 | |
| 0.064 | 0.046 | 0.072 | Interferon inducer | 0.072 0.032 DBMET00551 | DBMET00551 | |
| 0.032 | 0.015 | 0.05 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.03 0.017 DBMET00551 0.05 0.008 DBMET00570 | DBMET00570 | |
| 0.065 | 0.048 | 0.087 | Carbonic anhydrase V inhibitor | 0.087 0.032 DBMET00551 0.076 0.038 DBMET00570 | DBMET00551 | |
| 0.106 | 0.09 | 0.138 | Transcription factor STAT6 inhibitor | 0.138 0.035 DBMET00551 0.118 0.064 DBMET00570 | DBMET00551 | |
| 0.021 | 0.005 | 0.026 | Lysophosphatidic acid receptor 3 agonist | 0.026 0.004 DBMET00551 0.021 0.005 DBMET00570 | DBMET00551 | |
| 0.062 | 0.047 | 0.075 | Cannabinoid receptor agonist | 0.075 0.038 DBMET00570 | DBMET00570 | |
| 0.019 | 0.004 | 0.019 | DNA polymerase III polC-type inhibitor | |||
| 0.035 | 0.02 | 0.043 | Protein kinase (CK2) beta inhibitor | 0.043 0.01 DBMET00551 0.031 0.028 DBMET00570 | DBMET00551 | |
| 0.066 | 0.051 | 0.083 | Carbonic anhydrase VA inhibitor | 0.083 0.034 DBMET00551 0.075 0.041 DBMET00570 | DBMET00551 | |
| 0.043 | 0.029 | 0.058 | Oxytocin agonist | 0.058 0.018 DBMET00551 0.047 0.026 DBMET00570 | DBMET00551 | |
| 0.064 | 0.05 | 0.064 | Opioid mu receptor antagonist | |||
| 0.021 | 0.007 | 0.106 | Complement factor 1 inhibitor | 0.038 0.003 DBMET00551 0.106 0.002 DBMET00570 | DBMET00570 | |
| 0.022 | 0.009 | 0.025 | Alpha 2c adrenoreceptor agonist | 0.025 0.006 DBMET00551 0.023 0.008 DBMET00570 | DBMET00551 | |
| 0.02 | 0.007 | 0.024 | Purinergic P2Y1 agonist | 0.024 0.005 DBMET00551 0.02 0.007 DBMET00570 | DBMET00551 | |
| 0.072 | 0.059 | 0.093 | GABA aminotransferase inhibitor | 0.093 0.033 DBMET00551 0.072 0.059 DBMET00570 | DBMET00551 | |
| 0.031 | 0.019 | 0.04 | Nicotinic alpha3beta4 receptor agonist | 0.04 0.01 DBMET00551 0.031 0.019 DBMET00570 | DBMET00551 | |
| 0.046 | 0.034 | 0.067 | CC chemokine 4 receptor antagonist | 0.053 0.024 DBMET00551 0.067 0.011 DBMET00570 | DBMET00570 | |
| 0.021 | 0.009 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00551 0.023 0.007 DBMET00570 | DBMET00570 | |
| 0.074 | 0.062 | 0.086 | Interferon agonist | 0.086 0.043 DBMET00551 | DBMET00551 | |
| 0.02 | 0.008 | 0.023 | Telomerase stimulant | 0.023 0.005 DBMET00551 0.02 0.008 DBMET00570 | DBMET00551 | |
| 0.033 | 0.022 | 0.055 | ATR kinase inhibitor | 0.031 0.026 DBMET00551 0.055 0.006 DBMET00570 | DBMET00570 | |
| 0.032 | 0.021 | 0.037 | Cholesterol ester transfer protein antagonist | 0.037 0.015 DBMET00570 | DBMET00570 | |
| 0.036 | 0.026 | 0.054 | Arginase inhibitor | 0.054 0.013 DBMET00551 0.038 0.024 DBMET00570 | DBMET00551 | |
| 0.038 | 0.027 | 0.041 | Retinoid X receptor antagonist | 0.041 0.022 DBMET00551 0.036 0.029 DBMET00570 | DBMET00551 | |
| 0.027 | 0.017 | 0.044 | Nicotinic acid receptor 2 antagonist | 0.044 0.004 DBMET00551 0.041 0.005 DBMET00570 | DBMET00551 | |
| 0.024 | 0.014 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.009 DBMET00551 0.022 0.018 DBMET00570 | DBMET00551 | |
| 0.13 | 0.12 | 0.13 | Nitric oxide antagonist | |||
| 0.023 | 0.014 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 DBMET00551 0.023 0.014 DBMET00570 | DBMET00551 | |
| 0.045 | 0.035 | 0.062 | Thymidylate synthase inhibitor | 0.054 0.022 DBMET00551 0.062 0.016 DBMET00570 | DBMET00570 | |
| 0.045 | 0.036 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET00551 0.046 0.034 DBMET00570 | DBMET00551 | |
| 0.056 | 0.047 | 0.094 | Alpha 2 adrenoreceptor agonist | 0.094 0.017 DBMET00551 0.06 0.043 DBMET00570 | DBMET00551 | |
| 0.042 | 0.033 | 0.055 | Heme oxygenase inhibitor | 0.055 0.008 DBMET00551 0.043 0.03 DBMET00570 | DBMET00551 | |
| 0.036 | 0.027 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.055 | 0.047 | 0.067 | Carbonic anhydrase stimulant | 0.067 0.034 DBMET00551 0.055 0.047 DBMET00570 | DBMET00551 | |
| 0.037 | 0.029 | 0.043 | Potassium channel Kv1.1 blocker | 0.043 0.019 DBMET00551 0.037 0.029 DBMET00570 | DBMET00551 | |
| 0.121 | 0.113 | 0.121 | Heat shock protein 90 antagonist | |||
| 0.053 | 0.045 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.065 0.016 DBMET00551 0.053 0.045 DBMET00570 | DBMET00551 | |
| 0.122 | 0.115 | 0.151 | Cyclin-dependent kinase 8 inhibitor | 0.151 0.078 DBMET00551 0.143 0.087 DBMET00570 | DBMET00551 | |
| 0.046 | 0.039 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.064 0.012 DBMET00551 0.046 0.039 DBMET00570 | DBMET00551 | |
| 0.022 | 0.015 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 DBMET00551 | DBMET00551 | |
| 0.014 | 0.008 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET00551 0.02 0.004 DBMET00570 | DBMET00570 | |
| 0.028 | 0.021 | 0.044 | Liver X receptor beta antagonist | 0.034 0.016 DBMET00551 0.044 0.011 DBMET00570 | DBMET00570 | |
| 0.021 | 0.014 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.012 DBMET00551 | DBMET00551 | |
| 0.029 | 0.023 | 0.029 | Prostaglandin D2 agonist | |||
| 0.035 | 0.03 | 0.064 | Diamine oxidase inhibitor | 0.064 0.008 DBMET00551 0.044 0.019 DBMET00570 | DBMET00551 | |
| 0.018 | 0.013 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.07 | 0.065 | 0.07 | Metalloproteinase-2 inhibitor | 0.069 0.067 DBMET00570 | ||
| 0.013 | 0.008 | 0.017 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DBMET00551 0.013 0.008 DBMET00570 | DBMET00551 | |
| 0.028 | 0.023 | 0.04 | Peptide deformylase inhibitor | 0.04 0.014 DBMET00551 0.033 0.018 DBMET00570 | DBMET00551 | |
| 0.027 | 0.023 | 0.033 | 5 Hydroxytryptamine 6 agonist | 0.031 0.016 DBMET00551 0.033 0.013 DBMET00570 | DBMET00570 | |
| 0.037 | 0.032 | 0.083 | Toll-Like receptor 2 agonist | 0.083 0.016 DBMET00551 0.04 0.029 DBMET00570 | DBMET00551 | |
| 0.032 | 0.028 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.026 DBMET00551 | DBMET00551 | |
| 0.029 | 0.024 | 0.029 | Prostaglandin agonist | |||
| 0.108 | 0.103 | 0.108 | Calcium channel blocker | |||
| 0.014 | 0.01 | 0.014 | Angiotensin AT1B receptor antagonist | |||
| 0.029 | 0.025 | 0.035 | Epoxide hydrolase 1 inhibitor | 0.035 0.015 DBMET00551 0.031 0.022 DBMET00570 | DBMET00551 | |
| 0.119 | 0.116 | 0.119 | MAP3K9 inhibitor | |||
| 0.04 | 0.037 | 0.04 | Oleamide hydrolase inhibitor | |||
| 0.066 | 0.063 | 0.092 | Carbonic anhydrase XIII inhibitor | 0.092 0.042 DBMET00551 0.081 0.049 DBMET00570 | DBMET00551 | |
| 0.043 | 0.041 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.04 DBMET00551 0.043 0.04 DBMET00570 | ||
| 0.025 | 0.023 | 0.039 | Uridine phosphorylase inhibitor | 0.039 0.012 DBMET00551 0.025 0.023 DBMET00570 | DBMET00551 | |
| 0.04 | 0.038 | 0.048 | AICAR transformylase inhibitor | 0.048 0.025 DBMET00551 0.04 0.038 DBMET00570 | DBMET00551 | |
| 0.053 | 0.051 | 0.089 | Androgen agonist | 0.089 0.02 DBMET00551 0.055 0.049 DBMET00570 | DBMET00551 | |
| 0.011 | 0.01 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET00551 0.011 0.01 DBMET00570 | DBMET00551 | |
| 0.014 | 0.013 | 0.017 | Thromboxane A2 agonist | 0.017 0.008 DBMET00551 0.014 0.013 DBMET00570 | DBMET00551 | |
| 0.031 | 0.03 | 0.046 | Kainate receptor 2 antagonist | 0.046 0.018 DBMET00551 0.033 0.027 DBMET00570 | DBMET00551 | |
| 0.02 | 0.02 | 0.026 | Prostaglandin F2 alpha agonist | 0.026 0.012 DBMET00551 | DBMET00551 | |
| 0.044 | 0.044 | 0.051 | Bombesin 2 receptor antagonist | 0.051 0.032 DBMET00551 | DBMET00551 | |
| 0.058 | 0.057 | 0.081 | Histone deacetylase SIRT3 inhibitor | 0.081 0.018 DBMET00551 0.058 0.057 DBMET00570 | DBMET00551 | |
| 0.028 | 0.028 | 0.053 | Sirtuin 2 inhibitor | 0.053 0.012 DBMET00551 | DBMET00551 | |
| 0.016 | 0.016 | 0.017 | CC chemokine 9 receptor antagonist | 0.017 0.013 DBMET00551 0.017 0.012 DBMET00570 | DBMET00570 | |
| 0.016 | 0.016 | 0.033 | Cyclin T1 inhibitor | 0.021 0.01 DBMET00551 0.033 0.005 DBMET00570 | DBMET00570 | |
| 0.022 | 0.023 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.011 DBMET00551 | DBMET00551 | |
| 0.005 | 0.006 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.004 DBMET00570 | DBMET00570 | |
| 0.06 | 0.061 | 0.071 | Potassium channel (ATP-sensitive) blocker | 0.071 0.04 DBMET00570 | DBMET00570 | |
| 0.009 | 0.01 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00551 | DBMET00551 | |
| 0.095 | 0.097 | 0.128 | TRPA1 agonist | 0.128 0.049 DBMET00551 | DBMET00551 | |
| 0.015 | 0.016 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.012 DBMET00551 0.016 0.014 DBMET00570 | DBMET00551 | |
| 0.033 | 0.035 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.014 DBMET00551 0.034 0.029 DBMET00570 | DBMET00551 | |
| 0.07 | 0.072 | 0.087 | Carbonic anhydrase VI inhibitor | 0.087 0.049 DBMET00551 0.081 0.056 DBMET00570 | DBMET00551 | |
| 0.019 | 0.021 | 0.019 | Factor XIII inhibitor | 0.019 0.018 DBMET00551 | DBMET00551 | |
| 0.038 | 0.041 | 0.172 | Cathepsin F inhibitor | 0.064 0.005 DBMET00551 0.172 0.002 DBMET00570 | DBMET00570 | |
| 0.039 | 0.042 | 0.051 | Glutamate (mGluR group III) antagonist | 0.051 0.019 DBMET00551 0.04 0.038 DBMET00570 | DBMET00551 | |
| 0.038 | 0.041 | 0.054 | Nerve growth factor antagonist | 0.054 0.014 DBMET00551 | DBMET00551 | |
| 0.01 | 0.013 | 0.017 | Glucose-dependent insulinotropic receptor antagonist | 0.013 0.006 DBMET00551 0.017 0.004 DBMET00570 | DBMET00570 | |
| 0.03 | 0.033 | 0.037 | Retinoid X alpha receptor antagonist | 0.037 0.019 DBMET00551 0.033 0.026 DBMET00570 | DBMET00551 | |
| 0.023 | 0.027 | 0.042 | Sodium/glucose cotransporter 2 inhibitor | 0.042 0.008 DBMET00551 0.028 0.016 DBMET00570 | DBMET00551 | |
| 0.043 | 0.047 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 DBMET00551 0.053 0.033 DBMET00570 | DBMET00570 | |
| 0.006 | 0.01 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00551 | DBMET00551 | |
| 0.017 | 0.021 | 0.028 | Imidazoline I1 receptor antagonist | 0.028 0.008 DBMET00551 | DBMET00551 | |
| 0.058 | 0.062 | 0.093 | Nav1.7 sodium channel blocker | 0.093 0.026 DBMET00551 0.076 0.037 DBMET00570 | DBMET00551 | |
| 0.035 | 0.04 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET00570 | DBMET00570 | |
| 0.028 | 0.033 | 0.036 | Dipeptidyl peptidase II inhibitor | 0.034 0.02 DBMET00551 0.036 0.018 DBMET00570 | DBMET00570 | |
| 0.036 | 0.041 | 0.042 | Glutamate (mGluR group III) agonist | 0.042 0.031 DBMET00551 | DBMET00551 | |
| 0.008 | 0.014 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.006 DBMET00551 | DBMET00551 | |
| 0.069 | 0.075 | 0.135 | Calcium antagonist | 0.135 0.028 DBMET00551 0.083 0.061 DBMET00570 | DBMET00551 | |
| 0.09 | 0.096 | 0.102 | Protein kinase C gamma inhibitor | 0.102 0.073 DBMET00551 | DBMET00551 | |
| 0.092 | 0.098 | 0.118 | Cholesterol synthesis inhibitor | 0.118 0.067 DBMET00551 | DBMET00551 | |
| 0.071 | 0.078 | 0.101 | Ornithine decarboxylase inhibitor | 0.101 0.043 DBMET00551 | DBMET00551 | |
| 0.123 | 0.129 | 0.151 | Melanin inhibitor | 0.151 0.08 DBMET00551 | DBMET00551 | |
| 0.021 | 0.028 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.017 DBMET00551 | DBMET00551 | |
| 0.029 | 0.036 | 0.036 | Melatonin receptor 1A agonist | 0.036 0.019 DBMET00551 | DBMET00551 | |
| 0.14 | 0.147 | 0.209 | Insulin sensitizer | 0.209 0.065 DBMET00551 0.199 0.075 DBMET00570 | DBMET00551 | |
| 0.009 | 0.016 | 0.013 | Purine nucleoside phosphorylase inhibitor | 0.013 0.006 DBMET00551 | DBMET00551 | |
| 0.034 | 0.041 | 0.048 | Liver X receptor alpha agonist | 0.042 0.027 DBMET00551 0.048 0.021 DBMET00570 | DBMET00570 | |
| 0.024 | 0.031 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 DBMET00551 0.025 0.024 DBMET00570 | DBMET00551 | |
| 0.116 | 0.124 | 0.149 | Hexokinase inhibitor | 0.149 0.079 DBMET00551 0.128 0.107 DBMET00570 | DBMET00551 | |
| 0.022 | 0.03 | 0.027 | Acid ceramidase inhibitor | 0.027 0.014 DBMET00551 | DBMET00551 | |
| 0.018 | 0.026 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 DBMET00551 | DBMET00551 | |
| 0.015 | 0.024 | 0.018 | Hexokinase stimulant | 0.018 0.016 DBMET00551 0.018 0.017 DBMET00570 | DBMET00570 | |
| 0.049 | 0.058 | 0.078 | Botulinum neurotoxin type A inhibitor | 0.078 0.018 DBMET00551 | DBMET00551 | |
| 0.022 | 0.031 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET00551 0.025 0.019 DBMET00570 | DBMET00551 | |
| 0.023 | 0.032 | 0.028 | Thrombin receptor antagonist | 0.028 0.021 DBMET00551 | DBMET00551 | |
| 0.06 | 0.069 | 0.071 | Cathepsin G inhibitor | 0.071 0.053 DBMET00551 0.066 0.059 DBMET00570 | DBMET00551 | |
| 0.169 | 0.179 | 0.187 | Lipoxygenase inhibitor | 0.187 0.154 DBMET00551 | DBMET00551 | |
| 0.038 | 0.049 | 0.401 | Farnesyltransferase inhibitor | 0.401 0.003 DBMET00551 0.051 0.027 DBMET00570 | DBMET00551 | |
| 0.026 | 0.038 | 0.047 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET00551 0.047 0.01 DBMET00570 | DBMET00570 | |
| 0.027 | 0.038 | 0.035 | Phosphoglycerate kinase inhibitor | 0.035 0.024 DBMET00551 | DBMET00551 | |
| 0.026 | 0.037 | 0.053 | Liver X receptor beta agonist | 0.032 0.024 DBMET00551 0.053 0.01 DBMET00570 | DBMET00570 | |
| 0.017 | 0.029 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET00551 0.022 0.012 DBMET00570 | DBMET00570 | |
| 0.02 | 0.031 | 0.028 | CXC chemokine 2 receptor antagonist | 0.025 0.02 DBMET00551 0.028 0.016 DBMET00570 | DBMET00570 | |
| 0.034 | 0.046 | 0.043 | Thymidine kinase inhibitor | 0.043 0.025 DBMET00551 0.039 0.032 DBMET00570 | DBMET00551 | |
| 0.022 | 0.034 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET00551 | DBMET00551 | |
| 0.036 | 0.049 | 0.04 | Dihydroorotase inhibitor | 0.04 0.038 DBMET00551 | DBMET00551 | |
| 0.046 | 0.059 | 0.065 | Glucosylceramidase inhibitor | 0.065 0.026 DBMET00551 | DBMET00551 | |
| 0.029 | 0.042 | 0.043 | Glutamate (mGluR3) antagonist | 0.043 0.018 DBMET00551 | DBMET00551 | |
| 0.047 | 0.06 | 0.106 | MAP kinase kinase 9 inhibitor | 0.058 0.035 DBMET00551 0.106 0.009 DBMET00570 | DBMET00570 | |
| 0.013 | 0.026 | 0.019 | Neurokinin 1 agonist | 0.019 0.015 DBMET00551 | DBMET00551 | |
| 0.016 | 0.03 | 0.023 | Prostaglandin H2 antagonist | 0.023 0.02 DBMET00551 | DBMET00551 | |
| 0.016 | 0.029 | 0.029 | Geranylgeranyltransferase inhibitor | 0.029 0.01 DBMET00551 0.023 0.014 DBMET00570 | DBMET00551 | |
| 0.031 | 0.046 | 0.042 | Carbonic anhydrase IV inhibitor | 0.042 0.031 DBMET00551 | DBMET00551 | |
| 0.036 | 0.05 | 0.054 | Potassium channel Kv1.3 blocker | 0.054 0.025 DBMET00551 0.05 0.029 DBMET00570 | DBMET00551 | |
| 0.067 | 0.082 | 0.087 | Androgen antagonist | 0.087 0.058 DBMET00551 0.076 0.071 DBMET00570 | DBMET00551 | |
| 0.085 | 0.1 | 0.171 | Adenylate cyclase inhibitor | 0.171 0.034 DBMET00551 | DBMET00551 | |
| 0.033 | 0.048 | 0.045 | Leukocyte elastase inhibitor | 0.045 0.028 DBMET00551 | DBMET00551 | |
| 0.02 | 0.035 | 0.03 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.017 DBMET00551 | DBMET00551 | |
| 0.012 | 0.027 | 0.144 | Cathepsin S inhibitor | 0.144 0.004 DBMET00570 | DBMET00570 | |
| 0.012 | 0.027 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.017 0.013 DBMET00551 | DBMET00551 | |
| 0.022 | 0.038 | 0.038 | Potassium channel small-conductance Ca-activated activator | 0.038 0.016 DBMET00551 | DBMET00551 | |
| 0.05 | 0.066 | 0.068 | Matrix metalloproteinase inhibitor | 0.068 0.046 DBMET00570 | DBMET00570 | |
| 0.044 | 0.063 | 0.065 | Sphingosine kinase 2 inhibitor | 0.065 0.026 DBMET00551 0.051 0.045 DBMET00570 | DBMET00551 | |
| 0.037 | 0.056 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.04 DBMET00551 | DBMET00551 | |
| 0.119 | 0.138 | 0.143 | MAP kinase 3 inhibitor | 0.143 0.08 DBMET00551 0.139 0.086 DBMET00570 | DBMET00551 | |
| 0.07 | 0.089 | 0.114 | Caspase 7 inhibitor | 0.088 0.045 DBMET00551 0.114 0.018 DBMET00570 | DBMET00570 | |
| 0.042 | 0.061 | 0.052 | Elastase inhibitor | 0.052 0.039 DBMET00570 | DBMET00570 | |
| 0.012 | 0.032 | 0.021 | Prostaglandin EP2 agonist | 0.021 0.017 DBMET00551 | DBMET00551 | |
| 0.041 | 0.061 | 0.051 | 5 Hydroxytryptamine 4 antagonist | 0.051 0.036 DBMET00551 | DBMET00551 | |
| 0.043 | 0.063 | 0.052 | 5 Hydroxytryptamine 6 antagonist | 0.05 0.049 DBMET00551 0.052 0.045 DBMET00570 | DBMET00570 | |
| 0.014 | 0.035 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 DBMET00551 | DBMET00551 | |
| 0.025 | 0.046 | 0.033 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.025 DBMET00570 | DBMET00570 | |
| 0.078 | 0.099 | 0.108 | Xanthine oxidase inhibitor | 0.108 0.054 DBMET00551 | DBMET00551 | |
| 0.077 | 0.099 | 0.115 | Falcipain 3 inhibitor | 0.115 0.058 DBMET00551 0.088 0.084 DBMET00570 | DBMET00551 | |
| 0.044 | 0.067 | 0.057 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.043 DBMET00551 0.057 0.043 DBMET00570 | DBMET00570 | |
| 0.007 | 0.03 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET00551 | DBMET00551 | |
| 0.023 | 0.046 | 0.036 | Retinoid X alpha receptor agonist | 0.036 0.023 DBMET00551 | DBMET00551 | |
| 0.088 | 0.111 | 0.14 | Nav1.5 sodium channel blocker | 0.14 0.033 DBMET00551 0.096 0.092 DBMET00570 | DBMET00551 | |
| 0.043 | 0.066 | 0.048 | Dipeptidyl peptidase inhibitor | 0.048 0.047 DBMET00551 | DBMET00551 | |
| 0.024 | 0.048 | 0.032 | Carnitine palmitoyltransferase inhibitor | 0.032 0.026 DBMET00570 | DBMET00570 | |
| 0.067 | 0.091 | 0.107 | Glutathione S-transferase inhibitor | 0.107 0.032 DBMET00551 0.086 0.052 DBMET00570 | DBMET00551 | |
| 0.027 | 0.052 | 0.051 | Vascular adhesion protein 1 inhibitor | 0.045 0.019 DBMET00551 0.051 0.015 DBMET00570 | DBMET00570 | |
| 0.088 | 0.113 | 0.143 | Caspase 3 inhibitor | 0.124 0.054 DBMET00551 0.143 0.033 DBMET00570 | DBMET00570 | |
| 0.021 | 0.045 | 0.031 | Progesterone antagonist | 0.031 0.028 DBMET00570 | DBMET00570 | |
| 0.018 | 0.042 | 0.038 | Acetylcholine M4 receptor agonist | 0.038 0.016 DBMET00551 | DBMET00551 | |
| 0.106 | 0.13 | 0.12 | Acetylcholine M1 receptor antagonist | 0.12 0.109 DBMET00551 | DBMET00551 | |
| 0.046 | 0.071 | 0.068 | Cyclin D1 inhibitor | 0.068 0.031 DBMET00551 | DBMET00551 | |
| 0.093 | 0.118 | 0.137 | Toll-Like receptor 2 antagonist | 0.137 0.062 DBMET00551 | DBMET00551 | |
| 0.032 | 0.056 | 0.054 | Antimetabolite | 0.046 0.034 DBMET00551 0.054 0.029 DBMET00570 | DBMET00570 | |
| 0.005 | 0.03 | 0.062 | Glucagon agonist | 0.062 0.004 DBMET00551 | DBMET00551 | |
| 0.036 | 0.061 | 0.063 | Cannabinoid CB2 receptor agonist | 0.063 0.032 DBMET00570 | DBMET00570 | |
| 0.094 | 0.119 | 0.123 | Cytokine production inhibitor | 0.123 0.087 DBMET00551 0.113 0.097 DBMET00570 | DBMET00551 | |
| 0.031 | 0.057 | 0.043 | Vanilloid 3 antagonist | 0.043 0.017 DBMET00551 | DBMET00551 | |
| 0.036 | 0.062 | 0.052 | Cholesterol esterase inhibitor | 0.052 0.026 DBMET00551 0.049 0.032 DBMET00570 | DBMET00551 | |
| 0.031 | 0.056 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.033 DBMET00551 | DBMET00551 | |
| 0.042 | 0.068 | 0.054 | CC chemokine 2 receptor antagonist | 0.054 0.039 DBMET00570 | DBMET00570 | |
| 0.021 | 0.047 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.025 DBMET00551 | DBMET00551 | |
| 0.076 | 0.102 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | 0.089 0.073 DBMET00551 0.114 0.041 DBMET00570 | DBMET00570 | |
| 0.017 | 0.045 | 0.024 | ICAM 1 antagonist | 0.024 0.013 DBMET00551 | DBMET00551 | |
| 0.081 | 0.109 | 0.105 | Beta glucuronidase inhibitor | 0.105 0.063 DBMET00551 | DBMET00551 | |
| 0.04 | 0.068 | 0.066 | Cathepsin L inhibitor | 0.054 0.045 DBMET00551 0.066 0.032 DBMET00570 | DBMET00570 | |
| 0.013 | 0.042 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 DBMET00551 | DBMET00551 | |
| 0.013 | 0.041 | 0.051 | Vasopressin 1B antagonist | 0.051 0.006 DBMET00570 | DBMET00570 | |
| 0.022 | 0.05 | 0.027 | Glucosylceramidase stimulant | 0.027 0.021 DBMET00551 | DBMET00551 | |
| 0.1 | 0.129 | 0.17 | Cytidine deaminase inhibitor | 0.17 0.062 DBMET00551 | DBMET00551 | |
| 0.042 | 0.072 | 0.055 | Vanilloid 2 antagonist | 0.055 0.031 DBMET00551 | DBMET00551 | |
| 0.048 | 0.078 | 0.076 | 5 Hydroxytryptamine 3 agonist | 0.076 0.03 DBMET00551 | DBMET00551 | |
| 0.035 | 0.065 | 0.041 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 DBMET00551 | DBMET00551 | |
| 0.018 | 0.048 | 0.058 | Endothelial nitric-oxide synthase inhibitor | 0.058 0.008 DBMET00551 | DBMET00551 | |
| 0.054 | 0.085 | 0.075 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.055 DBMET00551 | DBMET00551 | |
| 0.048 | 0.079 | 0.055 | Leukotriene C antagonist | 0.055 0.043 DBMET00551 | DBMET00551 | |
| 0.003 | 0.034 | 0.349 | Neurokinin 3 agonist | 0.349 0.002 DBMET00551 | DBMET00551 | |
| 0.018 | 0.049 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 DBMET00570 | DBMET00570 | |
| 0.17 | 0.202 | 0.289 | Transcription factor NF kappa B inhibitor | 0.254 0.124 DBMET00551 0.289 0.1 DBMET00570 | DBMET00570 | |
| 0.046 | 0.079 | 0.076 | Heat shock protein 90 beta antagonist | 0.076 0.024 DBMET00551 | DBMET00551 | |
| 0.025 | 0.059 | 0.121 | Oxytocin antagonist | 0.121 0.008 DBMET00570 | DBMET00570 | |
| 0.075 | 0.109 | 0.128 | Alpha 2b adrenoreceptor antagonist | 0.128 0.052 DBMET00551 | DBMET00551 | |
| 0.006 | 0.04 | 0.016 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET00570 | DBMET00570 | |
| 0.033 | 0.067 | 0.048 | Glutamate (mGluR5) agonist | 0.048 0.028 DBMET00551 | DBMET00551 | |
| 0.041 | 0.075 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | 0.051 0.041 DBMET00551 | DBMET00551 | |
| 0.096 | 0.131 | 0.129 | Protein kinase stimulant | 0.129 0.084 DBMET00551 | DBMET00551 | |
| 0.091 | 0.126 | 0.149 | Sodium channel (voltage-gated) blocker | 0.149 0.055 DBMET00551 0.121 0.083 DBMET00570 | DBMET00551 | |
| 0.042 | 0.077 | 0.067 | Collagenase 3 inhibitor | 0.067 0.034 DBMET00570 | DBMET00570 | |
| 0.047 | 0.084 | 0.062 | I kappa B kinase 2 inhibitor | 0.062 0.044 DBMET00551 0.056 0.054 DBMET00570 | DBMET00551 | |
| 0.098 | 0.136 | 0.128 | DNA repair enzyme inhibitor | 0.126 0.061 DBMET00551 0.128 0.058 DBMET00570 | DBMET00570 | |
| 0.04 | 0.077 | 0.07 | Cyclin-dependent kinase 6 inhibitor | 0.056 0.046 DBMET00551 0.07 0.031 DBMET00570 | DBMET00570 | |
| 0.108 | 0.146 | 0.178 | Thiol protease inhibitor | 0.161 0.06 DBMET00551 0.178 0.049 DBMET00570 | DBMET00570 | |
| 0.026 | 0.064 | 0.053 | Glycine transporter inhibitor | 0.053 0.029 DBMET00570 | DBMET00570 | |
| 0.033 | 0.071 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.03 DBMET00551 | DBMET00551 | |
| 0.043 | 0.081 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 DBMET00551 | DBMET00551 | |
| 0.077 | 0.116 | 0.118 | AMP-activated protein kinase stimulant | 0.11 0.059 DBMET00551 0.118 0.051 DBMET00570 | DBMET00570 | |
| 0.053 | 0.092 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | 0.081 0.049 DBMET00551 | DBMET00551 | |
| 0.016 | 0.057 | 0.071 | Liver X receptor antagonist | 0.029 0.024 DBMET00551 0.071 0.006 DBMET00570 | DBMET00570 | |
| 0.017 | 0.058 | 0.033 | LFA antagonist | 0.033 0.012 DBMET00551 | DBMET00551 | |
| 0.021 | 0.063 | 0.047 | Cathepsin L1 inhibitor | 0.034 0.033 DBMET00551 0.047 0.021 DBMET00570 | DBMET00570 | |
| 0.016 | 0.058 | 0.031 | Cathepsin K inhibitor | 0.031 0.014 DBMET00570 | DBMET00570 | |
| 0.037 | 0.08 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | 0.049 0.048 DBMET00570 | DBMET00570 | |
| 0.042 | 0.086 | 0.109 | Sphingosine 1-phosphate receptor 4 agonist | 0.109 0.021 DBMET00551 | DBMET00551 | |
| 0.114 | 0.158 | 0.168 | Tumour necrosis factor antagonist | 0.165 0.082 DBMET00551 0.168 0.079 DBMET00570 | DBMET00570 | |
| 0.053 | 0.098 | 0.13 | Phosphodiesterase IV inhibitor | 0.13 0.029 DBMET00570 | DBMET00570 | |
| 0.065 | 0.11 | 0.114 | Urease inhibitor | 0.114 0.051 DBMET00551 0.098 0.069 DBMET00570 | DBMET00551 | |
| 0.062 | 0.108 | 0.081 | GABA A receptor agonist | 0.081 0.061 DBMET00551 | DBMET00551 | |
| 0.018 | 0.067 | 0.043 | Methionyl aminopeptidase 1 inhibitor | 0.043 0.01 DBMET00551 | DBMET00551 | |
| 0.057 | 0.107 | 0.088 | Myeloperoxidase inhibitor | 0.088 0.052 DBMET00551 | DBMET00551 | |
| 0.026 | 0.077 | 0.573 | Neurokinin 2 agonist | 0.573 0.002 DBMET00551 | DBMET00551 | |
| 0.025 | 0.076 | 0.043 | MAP3K5 inhibitor | 0.043 0.02 DBMET00551 | DBMET00551 | |
| 0.023 | 0.077 | 0.05 | NMDA 2A receptor antagonist | 0.05 0.038 DBMET00551 | DBMET00551 | |
| 0.045 | 0.1 | 0.065 | Protein kinase C beta inhibitor | 0.065 0.058 DBMET00551 | DBMET00551 | |
| 0.021 | 0.075 | 0.033 | Factor XIIIa inhibitor | 0.033 0.032 DBMET00551 | DBMET00551 | |
| 0.028 | 0.083 | 0.07 | Aromatase inhibitor | 0.07 0.034 DBMET00551 | DBMET00551 | |
| 0.027 | 0.082 | 0.042 | Sphingosine kinase 1 inhibitor | 0.038 0.036 DBMET00551 0.042 0.027 DBMET00570 | DBMET00570 | |
| 0.041 | 0.097 | 0.063 | Sphingosine kinase inhibitor | 0.058 0.043 DBMET00551 0.063 0.034 DBMET00570 | DBMET00570 | |
| 0.024 | 0.08 | 0.047 | Glutamate (mGluR group I) agonist | 0.047 0.034 DBMET00551 | DBMET00551 | |
| 0.022 | 0.079 | 0.042 | Acetylcholine M1 receptor agonist | 0.042 0.031 DBMET00551 | DBMET00551 | |
| 0.029 | 0.087 | 0.069 | mTOR inhibitor | 0.069 0.023 DBMET00570 | DBMET00570 | |
| 0.03 | 0.089 | 0.06 | Toll-Like receptor 8 antagonist | 0.053 0.038 DBMET00551 0.06 0.031 DBMET00570 | DBMET00570 | |
| 0.023 | 0.083 | 0.043 | Glutamate (mGluR1a) antagonist | 0.043 0.026 DBMET00551 | DBMET00551 | |
| 0.03 | 0.09 | 0.061 | Acetylcholine muscarinic agonist | 0.061 0.033 DBMET00551 | DBMET00551 | |
| 0.113 | 0.174 | 0.182 | I kappa B kinase epsilon inhibitor | 0.182 0.087 DBMET00551 | DBMET00551 | |
| 0.066 | 0.127 | 0.1 | Cyclin-dependent kinase 9 inhibitor | 0.1 0.062 DBMET00570 | DBMET00570 | |
| 0.109 | 0.171 | 0.198 | MAP kinase kinase 2 inhibitor | 0.198 0.083 DBMET00551 | DBMET00551 | |
| 0.045 | 0.11 | 0.071 | Leucine-rich repeat kinase 2 inhibitor | 0.071 0.068 DBMET00570 | DBMET00570 | |
| 0.059 | 0.125 | 0.084 | Potassium channel activator | 0.084 0.069 DBMET00570 | DBMET00570 | |
| 0.037 | 0.105 | 0.064 | 5 Hydroxytryptamine 3A antagonist | 0.064 0.05 DBMET00551 | DBMET00551 | |
| 0.034 | 0.105 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | 0.063 0.034 DBMET00551 | DBMET00551 | |
| 0.081 | 0.153 | 0.121 | Alkaline phosphatase inhibitor | 0.121 0.085 DBMET00551 | DBMET00551 | |
| 0.066 | 0.139 | 0.099 | GABA receptor agonist | 0.099 0.078 DBMET00551 | DBMET00551 | |
| 0.041 | 0.116 | 0.057 | 5 Hydroxytryptamine 5A antagonist | 0.057 0.051 DBMET00551 | DBMET00551 | |
| 0.1 | 0.175 | 0.186 | Pyruvate kinase inhibitor | 0.186 0.089 DBMET00551 | DBMET00551 | |
| 0.099 | 0.179 | 0.136 | Neuropeptide Y1 antagonist | 0.136 0.088 DBMET00551 | DBMET00551 | |
| 0.056 | 0.137 | 0.087 | Pim-3 kinase inhibitor | 0.087 0.062 DBMET00570 | DBMET00570 | |
| 0.06 | 0.141 | 0.101 | Alpha 2c adrenoreceptor antagonist | 0.101 0.065 DBMET00551 | DBMET00551 | |
| 0.043 | 0.125 | 0.066 | Alpha 2a adrenoreceptor antagonist | 0.066 0.063 DBMET00551 | DBMET00551 | |
| 0.111 | 0.193 | 0.172 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.172 0.119 DBMET00551 | DBMET00551 | |
| 0.025 | 0.107 | 0.038 | Plasmepsin II inhibitor | 0.038 0.034 DBMET00551 | DBMET00551 | |
| 0.033 | 0.116 | 0.073 | Cannabinoid CB1 receptor antagonist | 0.066 0.038 DBMET00551 0.073 0.032 DBMET00570 | DBMET00570 | |
| 0.077 | 0.161 | 0.155 | NADPH oxidase inhibitor | 0.155 0.051 DBMET00551 | DBMET00551 | |
| 0.099 | 0.183 | 0.219 | DNA methyltransferase I inhibitor | 0.219 0.06 DBMET00551 | DBMET00551 | |
| 0.04 | 0.125 | 0.055 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.055 0.054 DBMET00551 | DBMET00551 | |
| 0.035 | 0.122 | 0.094 | Phosphodiesterase 4B inhibitor | 0.094 0.028 DBMET00570 | DBMET00570 | |
| 0.013 | 0.101 | 0.044 | Liver X receptor alpha antagonist | 0.044 0.007 DBMET00570 | DBMET00570 | |
| 0.074 | 0.163 | 0.12 | Sodium channel blocker | 0.12 0.084 DBMET00551 | DBMET00551 | |
| 0.027 | 0.117 | 0.052 | EphB4 antagonist | 0.052 0.048 DBMET00570 | DBMET00570 | |
| 0.017 | 0.108 | 0.058 | Cannabinoid CB2 receptor antagonist | 0.058 0.031 DBMET00551 | DBMET00551 | |
| 0.041 | 0.133 | 0.085 | Gonadotropin-releasing hormone receptor agonist | 0.085 0.015 DBMET00551 | DBMET00551 | |
| 0.028 | 0.122 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.042 DBMET00551 | DBMET00551 | |
| 0.044 | 0.138 | 0.088 | Potassium channel (Ca-activated) activator | 0.088 0.066 DBMET00551 | DBMET00551 | |
| 0.046 | 0.143 | 0.074 | Adenosine A3 receptor antagonist | 0.074 0.052 DBMET00551 | DBMET00551 | |
| 0.013 | 0.111 | 0.075 | Vasopressin 2 antagonist | 0.075 0.009 DBMET00570 | DBMET00570 | |
| 0.159 | 0.26 | 0.228 | 15-Lipoxygenase inhibitor | 0.228 0.184 DBMET00551 | DBMET00551 | |
| 0.091 | 0.192 | 0.146 | LIM domain kinase 1 inhibitor | 0.146 0.102 DBMET00551 | DBMET00551 | |
| 0.054 | 0.158 | 0.121 | Anesthetic local | 0.121 0.066 DBMET00551 | DBMET00551 | |
| 0.073 | 0.178 | 0.141 | Nav1.2 sodium channel blocker | 0.141 0.063 DBMET00551 | DBMET00551 | |
| 0.026 | 0.132 | 0.055 | 5 Hydroxytryptamine 2A agonist | 0.055 0.052 DBMET00551 | DBMET00551 | |
| 0.092 | 0.199 | 0.131 | Hemostatic | 0.131 0.094 DBMET00551 0.121 0.112 DBMET00570 | DBMET00551 | |
| 0.058 | 0.169 | 0.095 | Potassium channel (Voltage-sensitive) activator | 0.095 0.06 DBMET00551 | DBMET00551 | |
| 0.059 | 0.172 | 0.12 | Nav1.3 sodium channel blocker | 0.12 0.074 DBMET00551 | DBMET00551 | |
| 0.03 | 0.146 | 0.078 | Cannabinoid receptor antagonist | 0.067 0.053 DBMET00551 0.078 0.042 DBMET00570 | DBMET00570 | |
| 0.083 | 0.201 | 0.187 | Aryl hydrocarbon receptor agonist | 0.187 0.11 DBMET00551 | DBMET00551 | |
| 0.052 | 0.173 | 0.118 | Insulin receptor antagonist | 0.118 0.044 DBMET00570 | DBMET00570 | |
| 0.149 | 0.27 | 0.497 | Sodium/bile acid cotransporter inhibitor | 0.497 0.004 DBMET00570 | DBMET00570 | |
| 0.091 | 0.216 | 0.21 | DNA methylase inhibitor | 0.21 0.072 DBMET00551 | DBMET00551 | |
| 0.024 | 0.154 | 0.064 | TRPA1 antagonist | 0.064 0.038 DBMET00551 | DBMET00551 | |
| 0.082 | 0.212 | 0.22 | Aurora-C kinase inhibitor | 0.157 0.043 DBMET00551 0.22 0.015 DBMET00570 | DBMET00570 | |
| 0.056 | 0.193 | 0.114 | Beta amyloid protein antagonist | 0.114 0.073 DBMET00551 | DBMET00551 | |
| 0.052 | 0.194 | 0.086 | Polo-like kinase-1 inhibitor | 0.082 0.079 DBMET00551 0.086 0.07 DBMET00570 | DBMET00570 | |
| 0.004 | 0.164 | 0.018 | Sodium/hydrogen exchanger inhibitor | 0.018 0.01 DBMET00570 | DBMET00570 | |
| 0.03 | 0.2 | 0.505 | ErbB-2 antagonist | 0.505 0.004 DBMET00570 | DBMET00570 | |
| 0.078 | 0.251 | 0.496 | Growth hormone agonist | 0.496 0.006 DBMET00551 | DBMET00551 | |
| 0.013 | 0.21 | 0.134 | Liver X receptor agonist | 0.134 0.005 DBMET00570 | DBMET00570 | |
| 0.003 | 0.204 | 0.06 | 2-Acylglycerol O-acyltransferase 2 inhibitor | 0.06 0.003 DBMET00570 | DBMET00570 | |
| 0.024 | 0.233 | 0.28 | Bombesin 1 receptor agonist | 0.28 0.003 DBMET00551 | DBMET00551 | |
| 0.029 | 0.245 | 0.194 | Focal adhesion kinase 1 inhibitor | 0.082 0.047 DBMET00551 0.194 0.005 DBMET00570 | DBMET00570 | |
| 0.003 | 0.242 | 0.072 | Human T-cell leukemia virus type I protease inhibitor | 0.072 0.003 DBMET00551 | DBMET00551 | |
| 0.034 | 0.273 | 0.103 | ErbB-3 antagonist | 0.103 0.039 DBMET00570 | DBMET00570 | |
| 0.002 | 0.245 | 0.015 | Immunosuppressant Cyclosporine-like | 0.015 0.005 DBMET00551 | DBMET00551 | |
| 0.004 | 0.264 | 0.042 | Glycine transporter 1 inhibitor | 0.042 0.02 DBMET00570 | DBMET00570 | |
| 0.125 | 0.413 | 0.523 | Cyclophilin D inhibitor | 0.523 0.044 DBMET00570 | DBMET00570 | |
| 0.033 | 0.322 | 0.078 | Lipocortins synthesis agonist | 0.077 0.016 DBMET00551 0.078 0.015 DBMET00570 | DBMET00570 | |
| 0.013 | 0.306 | 0.1 | Glucagon-like peptide 1 agonist | 0.1 0.022 DBMET00551 | DBMET00551 | |
| 0.03 | 0.325 | 0.373 | Caspase 9 inhibitor | 0.373 0.002 DBMET00570 | DBMET00570 | |
| 0.031 | 0.372 | 0.84 | MAP kinase kinase 8 inhibitor | 0.84 0.002 DBMET00570 | DBMET00570 | |
| 0.01 | 0.394 | 0.435 | Erythropoietin receptor agonist | 0.435 0.004 DBMET00551 | DBMET00551 | |
| 0.071 | 0.473 | 0.205 | Immunomodulator | 0.205 0.158 DBMET00570 | DBMET00570 | |
| 0.003 | 0.409 | 0.085 | Growth hormone secretagogue receptor agonist | 0.085 0.01 DBMET00570 | DBMET00570 | |
| 0.029 | 0.452 | 0.265 | Nav1.4 sodium channel blocker | 0.265 0.006 DBMET00551 | DBMET00551 | |
| 0.004 | 0.433 | 0.033 | Vasopressin 1A antagonist | 0.033 0.017 DBMET00570 | DBMET00570 | |
| 0.001 | 0.451 | 0.012 | Calcineurin inhibitor | 0.012 0.006 DBMET00551 | DBMET00551 | |
| 0.011 | 0.467 | 0.13 | Epidermal growth factor antagonist | 0.13 0.029 DBMET00570 | DBMET00570 | |
| 0.006 | 0.465 | 0.326 | CDK9/cyclin T1 inhibitor | 0.326 0.005 DBMET00570 | DBMET00570 | |
| 0.01 | 0.495 | 0.044 | Cholecystokinin B agonist | 0.044 0.019 DBMET00551 | DBMET00551 | |
| 0.002 | 0.5 | 0.038 | Growth hormone releasing factor antagonist | 0.038 0.01 DBMET00551 | DBMET00551 | |
| 0.016 | 0.513 | 0.453 | MAP kinase 9 inhibitor | 0.453 0.005 DBMET00570 | DBMET00570 | |
| 0.008 | 0.508 | 0.098 | p53 inhibitor | 0.098 0.004 DBMET00570 | DBMET00570 | |
| 0.003 | 0.552 | 0.019 | Corticosteroid-like | 0.019 0.018 DBMET00551 | DBMET00551 | |
| 0.012 | 0.562 | 0.1 | Bronchodilator | 0.1 0.064 DBMET00570 | DBMET00570 | |
| 0.006 | 0.573 | 0.115 | Mineralocorticoid receptor antagonist | 0.115 0.006 DBMET00570 | DBMET00570 | |
| 0.003 | 0.586 | 0.016 | Cholecystokinin agonist | 0.016 0.015 DBMET00551 | DBMET00551 | |
| 0.009 | 0.611 | 0.062 | Nitric oxide donor | 0.062 0.045 DBMET00570 | DBMET00570 | |
| 0.005 | 0.616 | 0.242 | Bromodomain-containing protein 4 inhibitor | 0.242 0.004 DBMET00570 | DBMET00570 | |
| 0.008 | 0.625 | 0.359 | MAP kinase 8 inhibitor | 0.359 0.005 DBMET00570 | DBMET00570 | |
| 0.024 | 0.661 | 0.078 | Prolactin release inhibitor | 0.078 0.013 DBMET00551 | DBMET00551 | |
| 0.004 | 0.649 | 0.056 | Geranylgeranyltransferase I inhibitor | 0.056 0.005 DBMET00551 | DBMET00551 | |
| 0.014 | 0.666 | 0.052 | Integrin alpha1beta1 antagonist | 0.052 0.006 DBMET00551 | DBMET00551 | |
| 0.004 | 0.668 | 0.061 | Protease activated receptor antagonist | 0.061 0.045 DBMET00551 | DBMET00551 | |
| 0.01 | 0.692 | 0.118 | Glucose-6-phosphate translocase inhibitor | 0.118 0.004 DBMET00551 | DBMET00551 | |
| 0.01 | 0.718 | 0.043 | ATM kinase inhibitor | 0.043 0.014 DBMET00570 | DBMET00570 | |
| 0.004 | 0.723 | 0.132 | DNA-dependent protein kinase inhibitor | 0.132 0.005 DBMET00570 | DBMET00570 | |
| 0.009 | 0.743 | 0.187 | Sirtuin 1 inhibitor | 0.187 0.004 DBMET00551 | DBMET00551 | |
| 0.005 | 0.758 | 0.062 | ZAP-70 protein tyrosine kinase inhibitor | 0.062 0.058 DBMET00570 | DBMET00570 | |
| 0.016 | 0.783 | 0.214 | Toll-Like receptor 7 agonist | 0.214 0.184 DBMET00570 | DBMET00570 | |
| 0.007 | 0.782 | 0.115 | Purinergic P2X2 antagonist | 0.115 0.023 DBMET00570 | DBMET00570 | |
| 0.004 | 0.787 | 0.339 | Phosphodiesterase 4C inhibitor | 0.339 0.004 DBMET00570 | DBMET00570 | |
| 0.014 | 0.799 | 0.206 | Toll-Like receptor agonist | 0.206 0.194 DBMET00570 | DBMET00570 | |
| 0.014 | 0.812 | 0.069 | DNA helicase inhibitor | 0.069 0.018 DBMET00570 | DBMET00570 | |
| 0.004 | 0.812 | 0.049 | Bombesin 1 receptor antagonist | 0.049 0.014 DBMET00551 | DBMET00551 | |
| 0.054 | 0.877 | 0.613 | ErbB-1 antagonist | 0.613 0.004 DBMET00570 | DBMET00570 | |
| 0.002 | 0.832 | 0.149 | Free fatty acid receptor 1 agonist | 0.149 0.003 DBMET00570 | DBMET00570 | |
| 0.009 | 0.844 | 0.692 | Insulin secretagoues | 0.148 0.076 DBMET00551 0.692 0.003 DBMET00570 | DBMET00570 | |
| 0.004 | 0.863 | 0.349 | Phosphodiesterase 4D inhibitor | 0.349 0.005 DBMET00570 | DBMET00570 | |
| 0.003 | 0.89 | 0.412 | Phosphodiesterase 4A inhibitor | 0.412 0.004 DBMET00570 | DBMET00570 | |
| 0.01 | 0.923 | 0.072 | Parathyroid hormone antagonist | 0.072 0.006 DBMET00551 | DBMET00551 | |
| 0.004 | 0.933 | 0.157 | Histone deacetylase class III inhibitor | 0.157 0.039 DBMET00551 | DBMET00551 | |
| 0.004 | 0.94 | 0.113 | Ca(v)2.2 blocker | 0.113 0.041 DBMET00570 | DBMET00570 | |
| 0.011 | 0.952 | 0.253 | Hepatoprotectant | 0.253 0.042 DBMET00551 | DBMET00551 | |
| 0.004 | 0.951 | 0.046 | Nicotinic acid receptor 1 agonist | 0.046 0.023 DBMET00551 | DBMET00551 | |
| 0.005 | 0.969 | 0.083 | Factor XII inhibitor | 0.083 0.061 DBMET00551 | DBMET00551 | |
| 0.007 | 0.971 | 0.296 | Histone deacetylase SIRT1 inhibitor | 0.296 0.008 DBMET00551 | DBMET00551 | |
| 0.005 | 0.986 | 0.467 | Hypoglycemic | 0.467 0.019 DBMET00570 | DBMET00570 | |
| 0.006 | 0.989 | 0.079 | Ca(v)3.2 blocker | 0.079 0.015 DBMET00570 | DBMET00570 | |
| 0.001 | 0.989 | 0.031 | CXC chemokine 3 receptor antagonist | 0.031 0.022 DBMET00570 | DBMET00570 | |
| 0.003 | 0.991 | 0.347 | Lipase inhibitor | 0.347 0.003 DBMET00570 | DBMET00570 | |
| 0.002 | 0.991 | 0.043 | Nicotinic receptor beta4 subunit antagonist | 0.043 0.02 DBMET00551 | DBMET00551 | |
| 0.003 | 0.996 | 0.159 | Falcipain 2 inhibitor | 0.159 0.025 DBMET00570 | DBMET00570 | |
| 0.002 | 0.995 | 0.066 | Secretase gamma inhibitor | 0.066 0.015 DBMET00570 | DBMET00570 | |
| 0.003 | 0.996 | 0.159 | Falcipain inhibitor | 0.159 0.027 DBMET00570 | DBMET00570 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |